Openbookopenbook
Equity
AppYea Inc(APYP)
USD --+0.00%
Reward39Moderate
Risk68Medium-High
📊75%Data
Revenue down 85% YoY
APYP
+0.0 · +0.00%
USD · OTCQB
AppYea Inc | Technology
Earnings Deterioration
Market Cap:15.50M
ℹ️
Reward Rating
39
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
68
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on APYP to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is AppYea Inc?

, a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring.

APYP · Verdict

Limited reward · elevated risk

APYP's standout is volatility; cash flow and profitability weigh on the picture.

Based on 88% data coverage

APYP · Verdict

What’s working & what to watch

Strengths 1

  • Volatility80/100

    Top decile vs peers

Watchouts 4

  • Cash flow7/100

    -7575% free-cash-flow margin

  • Profitability9/100

    -188713% net margin · -343% ROE

  • Balance sheet23/100

    Current ratio 0.07

  • Growth41/100

    Earnings +237.1% CAGR

Model-based scoring. For information only — not financial advice.

What is AppYea Inc?

, a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. The company developed the AppySleep app, an application with sensors that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns during sleep and identifies sleep apnea episodes without direct contact with the user; and AppySleep PRO, a wristband for the treatment of sleep apnea using biofeedback in combination with the AppySleep LAB app. The company is listed on the OTCQB in USA, operating in the Technology sector, with a market capitalisation of 15.50M.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (39)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorTechnology
Market Cap15.50M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0346
52 Week Low0.0057
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding891M
No. of Employees17
IndustrySoftware - Application
ExchangeOTCQB
Beta0.409
CurrencyUSD
Websitewww.appyea.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.